| Joseph M Zabramski, MD | |
|
2910 N 3rd Ave, Phoenix, AZ 85013-4434 | |
| (602) 406-3465 | |
| (602) 406-6157 |
| Full Name | Joseph M Zabramski |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 2910 N 3rd Ave, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578550125 | NPI | - | NPPES |
| 270538 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 14488 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph M Zabramski, MD 2910 N 3rd Ave, Phoenix, AZ 85013-4434 Ph: (602) 406-3465 | Joseph M Zabramski, MD 2910 N 3rd Ave, Phoenix, AZ 85013-4434 Ph: (602) 406-3465 |
News Archive
Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder (OAB), a serious condition that can severely impact patients' lives. This new campaign, conducted in partnership with leading patient advocacy groups focused on women's health will help to raise awareness of the prevalence of bladder control problems and encourage patients to find effective treatment options – including and beyond medications.
The American Chemistry Council (ACC) offers the following comments regarding the study published today in PLOS ONE by the Cincinnati Cancer Center researchers Pheruza Tarapore, et al. Quotes from the following may be attributed to Steven G. Hentges, Ph.D. of ACC's Polycarbonate/BPA Global Group.
Now, a new paper published on the preprint server medRxiv* reports the results of an analysis of the association between the genetic variants in the patients and the clinical progression of the disease. The study included 332 patients hospitalized with COVID-19 in a single-center, with widely varying laboratory and clinical features. There were 25, 12, and 17 patients with asymptomatic, mild, and critical disease.
A new study using DNA-based and protein HIV vaccines in various combinations shows that antibody and cellular immune response occurs within 6 weeks from the date of vaccination, and the combination must be administered together for the most rapid protection. This will enable more large-scale testing of the vaccine for effectiveness. About 40 million people today have HIV infections, and 1.2 million deaths a year are related to this infection.
› Verified 7 days ago
Curtis A Dickman, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2910 N 3rd Ave, Phoenix, AZ 85013 Phone: 602-406-3632 Fax: 602-406-4187 | |
Dr. Naresh P Patel, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
James Zhou, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 350 W Thomas Rd, Phoenix, AZ 85013 Phone: 602-406-4958 | |
Dr. Mark Edward Oppenlander, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 19636 N 27th Ave Ste 203, Phoenix, AZ 85027 Phone: 235-625-0506 Fax: 623-562-5051 | |
Dr. Erik I Curtis, M.D., M.S. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2222 E Highland Ave Ste 222, Phoenix, AZ 85016 Phone: 602-603-0971 | |
Dr. Michael T Lawton, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave, Phoenix, AZ 85013 Phone: 602-406-3489 Fax: 602-406-4402 | |
Dr. Jonathan Seth Hott, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 9225 N 3rd St, Suite 100, Phoenix, AZ 85020 Phone: 602-943-4509 Fax: 602-943-0348 |